| 000 | 01899 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515095120.0 | ||
| 264 | 0 | _c20080407 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1521-0111 | ||
| 024 | 7 |
_a10.1124/mol.107.040782 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPlaumann, Silke | |
| 245 | 0 | 0 |
_aActivation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cMar 2008 |
||
| 300 |
_a652-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aDNA Fragmentation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aFormazans _xmetabolism |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xanalysis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 650 | 0 | 4 |
_aTetrazolium Salts _xmetabolism |
| 650 | 0 | 4 |
_abcl-X Protein _xgenetics |
| 700 | 1 | _aBlume, Roland | |
| 700 | 1 | _aBörchers, Svenja | |
| 700 | 1 | _aSteinfelder, Hans Jürgen | |
| 700 | 1 | _aKnepel, Willhart | |
| 700 | 1 | _aOetjen, Elke | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 73 _gno. 3 _gp. 652-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.107.040782 _zAvailable from publisher's website |
| 999 |
_c17557737 _d17557737 |
||